Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

661 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Dysgonic fermenter type 2 infection.
Zumla A. Zumla A. Lancet. 1989 Sep 9;2(8663):627. doi: 10.1016/s0140-6736(89)90756-3. Lancet. 1989. PMID: 2570325 No abstract available.
Exploring the evidence base for national and regional policy interventions to combat resistance.
Dar OA, Hasan R, Schlundt J, Harbarth S, Caleo G, Dar FK, Littmann J, Rweyemamu M, Buckley EJ, Shahid M, Kock R, Li HL, Giha H, Khan M, So AD, Bindayna KM, Kessel A, Pedersen HB, Permanand G, Zumla A, R√łttingen JA, Heymann DL. Dar OA, et al. Among authors: zumla a. Lancet. 2016 Jan 16;387(10015):285-95. doi: 10.1016/S0140-6736(15)00520-6. Epub 2015 Nov 18. Lancet. 2016. PMID: 26603921 Review.
Corticosteroid therapy for pneumonia.
Zumla A, Bates M, Maeurer M. Zumla A, et al. Lancet. 2015 Sep 5;386(9997):955. doi: 10.1016/S0140-6736(15)00065-3. Lancet. 2015. PMID: 26369471 No abstract available.
New global estimates of malaria deaths.
Bates M, O'Grady J, Mudenda V, Shibemba A, Zumla A. Bates M, et al. Among authors: zumla a. Lancet. 2012 Aug 11;380(9841):560-1. doi: 10.1016/S0140-6736(12)61323-3. Lancet. 2012. PMID: 22883498 No abstract available.
Community-based interventions to reduce maternal mortality.
Ahmed Y, Mwaba P, Grange J, Green C, Zumla A. Ahmed Y, et al. Among authors: zumla a. Lancet. 2010 Feb 6;375(9713):457-8; author reply 458-9. doi: 10.1016/S0140-6736(10)60189-4. Lancet. 2010. PMID: 20152533 No abstract available.
Mycobacterium vaccae (SRL172) immunotherapy as an adjunct to standard antituberculosis treatment in HIV-infected adults with pulmonary tuberculosis: a randomised placebo-controlled trial.
Mwinga A, Nunn A, Ngwira B, Chintu C, Warndorff D, Fine P, Darbyshire J, Zumla A; LUSKAR collaboration. Mwinga A, et al. Among authors: zumla a. Lancet. 2002 Oct 5;360(9339):1050-5. doi: 10.1016/S0140-6736(02)11141-X. Lancet. 2002. PMID: 12383985 Clinical Trial.
Tuberculosis and HIV infection.
Zumla A, Chintu C. Zumla A, et al. Lancet. 1994 Apr 2;343(8901):851-2. doi: 10.1016/s0140-6736(94)92051-6. Lancet. 1994. PMID: 7908093 No abstract available.
Early treatment outcomes and HIV status of patients with extensively drug-resistant tuberculosis in South Africa: a retrospective cohort study.
Dheda K, Shean K, Zumla A, Badri M, Streicher EM, Page-Shipp L, Willcox P, John MA, Reubenson G, Govindasamy D, Wong M, Padanilam X, Dziwiecki A, van Helden PD, Siwendu S, Jarand J, Menezes CN, Burns A, Victor T, Warren R, Grobusch MP, van der Walt M, Kvasnovsky C. Dheda K, et al. Among authors: zumla a. Lancet. 2010 May 22;375(9728):1798-807. doi: 10.1016/S0140-6736(10)60492-8. Lancet. 2010. PMID: 20488525
WHO recommendations for multidrug-resistant tuberculosis - Authors' reply.
Sotgiu G, Tiberi S, D'Ambrosio L, Centis R, Zumla A, Migliori GB. Sotgiu G, et al. Among authors: zumla a. Lancet. 2016 Nov 5;388(10057):2234-2235. doi: 10.1016/S0140-6736(16)31465-9. Lancet. 2016. PMID: 27825499 No abstract available.
WHO's 2013 global report on tuberculosis: successes, threats, and opportunities.
Zumla A, George A, Sharma V, Herbert N, Baroness Masham of Ilton. Zumla A, et al. Lancet. 2013 Nov 30;382(9907):1765-7. doi: 10.1016/S0140-6736(13)62078-4. Epub 2013 Oct 23. Lancet. 2013. PMID: 24269294 No abstract available.
661 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page